Patent Exclusivity Health Checks for Biologics: Are Your U.S. Patents Ready to Maximize ROI?

As part of Strafford Publications' webinar series, Finnegan partners Paul Barker, Steven O'Connor, and Sanya Sukduang will discuss strategies to improve U.S. patents that may be subject to litigation under the Biologics Price Competition and Innovation Act (BPCIA). The program will also consider current information on PTAB challenges of patents directed to innovative biologics products and lessons learned from those proceedings. For more information, or to register, please see Strafford Publications' website.